Sign in
MRUS Stock Price, Chart, Stats & News
Merus N.V.
Save
Merus N.V. (MRUS) does not currently pay a dividend.
6.83B
Market cap
–
Current P/E
–
Forward P/E
MRUS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -207.03% |
Operating margin | -652.96% |
Pretax margin | -638.43% |
Net margin | -658.85% |
Effective tax rate | -3.20% |
ROA | -45.19% |
ROE | -50.79% |
D/E | 0.02x |
Interest coverage ratio | – |
MRUS valuation
P/E | – |
P/S | 128.91x |
P/B | 10.29x |
P/CF | -21.47x |
P/FCF | -21.47x |
P/OCF | -21.47x |
PEG | -5.41x |
EV multiple | -22.03x |
About
Merus N. V. is a clinical-stage immuno-oncology firm based in the Netherlands, specializing in the discovery and advancement of bispecific antibody therapies. Established in 2003, the company maintains its headquarters in Utrecht.
Similar securities
Based on sector and market capitalization
Report issue